(Q35798244)

10 August 2017

1 reference

title

Depression in epilepsy: ignoring clinical expression of neuronal network dysfunction? (English)

1 reference

10 August 2017

1

Frank G Gilliam

1 reference

10 August 2017

Juan Santos

2

1 reference

10 August 2017

Victoria Vahle

3

1 reference

10 August 2017

Jewell Carter

4

1 reference

10 August 2017

Kelly Brown

5

1 reference

10 August 2017

Hrvoje Hecimovic

6

1 reference

10 August 2017

publication date

1 January 2004

1 reference

10 August 2017

1 reference

10 August 2017

volume

45 Suppl 2

1 reference

10 August 2017

page(s)

28-33

1 reference

Treatment of depressive disorders in epilepsy patients.

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2004.452005.X

Depression but not seizure frequency predicts quality of life in treatment-resistant epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2004.452005.X

Cerebral metabolism and depression in patients with complex partial seizures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2004.452005.X

Subgenual prefrontal cortex abnormalities in mood disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2004.452005.X

Depression in complex partial seizures. Electroencephalography and cerebral metabolic correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2004.452005.X

Depression and schizophrenia in epilepsy: social and biological risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2004.452005.X

Combined adrenal myelolipoma and medullary hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2004.452005.X

Psychiatric and neurologic predictors of psychogenic pseudoseizure outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2004.452005.X

Effect of psychotropic medications on seizure control in patients with epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2004.452005.X

Psychiatric comorbidity, health, and function in epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2004.452005.X

Optimizing health outcomes in active epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2004.452005.X

Influence of mood and adjustment to cancer on compliance with chemotherapy among breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2004.452005.X

Relationship between psychological status and compliance in a sample of patients treated for cancer of the head and neck.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2004.452005.X

Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: prospective assessment with implications for enhancing compliance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2004.452005.X

Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2004.452005.X

Patient-oriented outcome assessment after temporal lobectomy for refractory epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2004.452005.X

Psychological status, syndromatic measures, and compliance with nasal CPAP therapy for sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2004.452005.X

10.1111/J.0013-9580.2004.452005.X

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference